Parker-Hannifin Corporation · PH · FY2027 Q1 · Calendar Q4 2026
Parker-Hannifin lifts FY2027 outlook as broad demand and backlog strengthen
The quarter’s record results, strong order momentum and raised FY2027 outlook support a constructive growth picture. Whether that persists depends on industrial demand holding up and Filtration Group integration delivering its expected contribution.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about PH FY2027 Q1
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Management raised full-year FY2027 revenue-growth guidance to 16–19% and put organic growth at a 9% midpoint. The call also highlighted a record $13.7 billion backlog and a larger filtration platform following the Filtration Group acquisition.
Guidance delta
Raised: FY2027 revenue growth is now guided at 16–19%, with organic growth at a 9% midpoint. Filtration Group is expected to add $1.85 billion of FY2027 sales and $40 million of synergies this year.
Key takeaways
- Q1 delivered record sales and EPS, with double-digit organic growth for the first time in three years.
- Backlog reached $13.7 billion, providing evidence of strong order momentum.
- Management cited demand across aerospace, industrial, life sciences, HVAC and transportation.
- Data-center cooling contributes about 1.5% of sales, according to management analysis.
- The raised outlook contrasts with risks from a moderating industrial cycle and acquisition integration.
Management priorities
- Integrate Filtration Group through the Parker integration playbook and Kaizen events.
- Pursue $220 million in cost synergies and more than 30% adjusted EBITDA margin for Filtration Group.
- Invest in capacity through Kaizen and the Parker Link system to meet demand.
Follow PH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 6, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 14, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 12, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 9, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Aug 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 11, 2026 |
| UBS | Buy | Buy | Maintain | Aug 7, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 7, 2026 |
| Susquehanna | Positive | Positive | Maintain | Aug 7, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 7, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Aug 7, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 26, 2026 |
| Stifel | Hold | Hold | Maintain | Apr 10, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 27, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 24, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jan 30, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 17, 2025 |
| Baird | Outperform | Outperform | Maintain | Nov 12, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 10, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Sep 4, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 8, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Apr 3, 2025 |
| B of A Securities | Buy | Buy | Maintain | May 17, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 5, 2023 |
| Gordon Haskett | Buy | Hold | Upgrade | Jun 16, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Dec 17, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 15, 2019 |
| Vertical Research | Hold | Buy | Downgrade | Feb 1, 2019 |
| Cowen & Co. | Underperform | Market Perform | Downgrade | Oct 15, 2018 |
| Buckingham Research | Buy | Neutral | Upgrade | Sep 14, 2018 |
| Buckingham | Buy | Neutral | Upgrade | Sep 14, 2018 |
| Argus | Hold | Buy | Downgrade | Aug 14, 2018 |
| Aegis Capital | Hold | Hold | Maintain | Dec 9, 2016 |
| Avondale Partners | Perform | Market Perform | Maintain | Apr 7, 2016 |
| ISI Group | Buy | Neutral | Upgrade | Aug 7, 2014 |
| MKM Partners | Buy | Buy | Maintain | Apr 30, 2014 |
| Longbow Research | Neutral | Underperform | Upgrade | Apr 29, 2013 |
| RBC Capital | Perform | Sector Perform | Maintain | Feb 15, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $918.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Analyst unavailable | $1,002 | $963.34 | +9.1% | Oct 19, 2026 |
| Mizuho Securities | Analyst unavailable | $1,200 | $956.32 | +30.7% | Oct 15, 2026 |
| UBS | Analyst unavailable | $950 | $960.6 | +3.4% | Oct 14, 2026 |
| Wells Fargo | Analyst unavailable | $1,050 | $974.98 | +14.3% | Sep 24, 2026 |
| Bernstein | Varun Govindaraj | $1,218 | $1,057.28 | +32.6% | Aug 14, 2026 |
| Truist Financial | Analyst unavailable | $1,358 | $1,079.69 | +47.9% | Aug 7, 2026 |
| Stifel Nicolaus | Nathan Jones | $1,075 | $1,081.58 | +17.1% | Aug 7, 2026 |
| BMO Capital | Daniel DiCicco | $1,214 | $1,069.8 | +32.2% | Aug 7, 2026 |
| UBS | Amit Mehrotra | $1,250 | $1,069.8 | +36.1% | Aug 7, 2026 |
| KeyBanc | Analyst unavailable | $1,210 | $1,069.8 | +31.8% | Aug 7, 2026 |
| Bernstein | Varun Govindaraj | $1,037 | $973.1 | +12.9% | Jul 16, 2026 |
| Truist Financial | Jamie Cook | $1,269 | $963.81 | +38.2% | Jul 2, 2026 |
| Bernstein | Varun Govindaraj | $1,026 | $905.53 | +11.7% | Jun 9, 2026 |
| Wells Fargo | Joseph O'Dea | $950 | $866.96 | +3.4% | May 26, 2026 |
| Evercore ISI | Analyst unavailable | $1,064 | $870.1 | +15.9% | May 11, 2026 |
| Truist Financial | Analyst unavailable | $1,147 | $889.27 | +24.9% | May 1, 2026 |
| Mizuho Securities | Brett Linzey | $1,050 | $895.3 | +14.3% | May 1, 2026 |
| Stifel Nicolaus | Analyst unavailable | $1,000 | $983.17 | +8.9% | Apr 10, 2026 |
| BMO Capital | Analyst unavailable | $1,090 | $901.46 | +18.7% | Mar 26, 2026 |
| Morgan Stanley | Analyst unavailable | $1,038 | $1,018.77 | +13.0% | Feb 24, 2026 |
| Truist Financial | Analyst unavailable | $1,139 | $936.2 | +24.0% | Jan 30, 2026 |
| KeyBanc | Analyst unavailable | $1,100 | $948.4 | +19.8% | Jan 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $965 | $948.4 | +5.1% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $1,050 | $948.4 | +14.3% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $1,020 | $948.4 | +11.1% | Jan 30, 2026 |
| Industrial Alliance Securities | Analyst unavailable | $1,032 | $948.4 | +12.4% | Jan 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $941 | $932.7 | +2.5% | Jan 23, 2026 |
| Morgan Stanley | Christopher Snyder | $945 | $931.66 | +2.9% | Jan 14, 2026 |
| Barclays | Analyst unavailable | $990 | $928.76 | +7.8% | Jan 7, 2026 |
| Wells Fargo | Joseph O'Dea | $1,000 | $928.76 | +8.9% | Jan 7, 2026 |
| KeyBanc | Jeffrey Hammond | $1,050 | $906.89 | +14.3% | Jan 6, 2026 |
| Truist Financial | Analyst unavailable | $1,097 | $874.17 | +19.5% | Dec 18, 2025 |
| Stifel Nicolaus | Analyst unavailable | $869 | $871.56 | -5.4% | Dec 16, 2025 |
| Goldman Sachs | Analyst unavailable | $1,000 | $883.45 | +8.9% | Dec 16, 2025 |
| Barclays | Julian Mitchell | $950 | $869.2 | +3.4% | Dec 4, 2025 |
| BNP Paribas | Analyst unavailable | $1,020 | $869.2 | +11.1% | Dec 4, 2025 |
| Susquehanna | Philip Walsh | $1,000 | $857.93 | +8.9% | Nov 12, 2025 |
| Truist Financial | Analyst unavailable | $977 | $844.01 | +6.4% | Nov 9, 2025 |
| KeyBanc | Analyst unavailable | $935 | $839.75 | +1.8% | Nov 7, 2025 |
| Stifel Nicolaus | Analyst unavailable | $723 | $733.59 | -21.3% | Oct 20, 2025 |
| Mizuho Securities | Analyst unavailable | $825 | $726.16 | -10.2% | Oct 17, 2025 |
| KeyBanc | Jeffrey Hammond | $825 | $728.66 | -10.2% | Oct 14, 2025 |
| Truist Financial | Jamie Cook | $910 | $750.68 | -0.9% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $785 | $758.15 | -14.5% | Oct 1, 2025 |
| Raymond James | Tim Thein | $845 | $727.74 | -8.0% | Aug 8, 2025 |
| Mizuho Securities | Brett Linzey | $785 | $680.4 | -14.5% | May 16, 2025 |
| Argus Research | John Eade | $680 | $613.92 | -26.0% | May 6, 2025 |
| Barclays | Analyst unavailable | $750 | $634.66 | -18.3% | Mar 10, 2025 |
| Wells Fargo | Joseph O'Dea | $710 | $635.23 | -22.7% | Jan 7, 2025 |
| UBS | Amit Mehrotra | $842 | $569.81 | -8.3% | Nov 13, 2024 |
| KeyBanc | Jeffrey Hammond | $725 | $637.15 | -21.1% | Oct 14, 2024 |
| Mizuho Securities | Brett Linzey | $665 | $626.05 | -27.6% | Sep 20, 2024 |
| Argus Research | John Eade | $650 | $590.84 | -29.2% | Aug 16, 2024 |
| Barclays | Julian Mitchell | $650 | $568.08 | -29.2% | Aug 9, 2024 |
| Raymond James | Tim Thein | $610 | $504.22 | -33.6% | Jun 27, 2024 |
| Barclays | Julian Mitchell | $610 | $513.08 | -33.6% | Jun 4, 2024 |
| Mizuho Securities | Brett Linzey | $650 | $529.83 | -29.2% | May 28, 2024 |
| KeyBanc | Jeffrey Hammond | $640 | $544.48 | -30.3% | May 17, 2024 |
| Goldman Sachs | Joe Ritchie | $700 | $544.4 | -23.8% | May 17, 2024 |
| Argus Research | John Eade | $590 | $536.18 | -35.8% | May 6, 2024 |
| Mizuho Securities | Brett Linzey | $550 | $530.68 | -40.1% | May 3, 2024 |
| Stifel Nicolaus | Nathan Jones | $629 | $559.06 | -31.5% | Apr 3, 2024 |
| Truist Financial | Jamie Cook | $602 | $539.56 | -34.4% | Mar 13, 2024 |
| Mizuho Securities | Brett Linzey | $290 | $271.54 | -68.4% | May 8, 2022 |
| Stifel Nicolaus | Nathan Jones | $338 | $273.87 | -63.2% | Apr 18, 2022 |
| Barclays | Julian Mitchell | $350 | $274.43 | -61.9% | Apr 5, 2022 |
| Jefferies | Stephen Volkmann | $350 | $283.85 | -61.9% | Mar 5, 2022 |
| Goldman Sachs | Joe Ritchie | $375 | $313.07 | -59.2% | Dec 12, 2021 |
| Cowen & Co. | Joseph C Giordano | $260 | $328.67 | -71.7% | Nov 19, 2021 |
| J.P. Morgan | Ann Duignan | $310 | $323.67 | -66.2% | Nov 5, 2021 |
| KeyBanc | Jeffrey Hammond | $385 | $323.67 | -58.1% | Nov 5, 2021 |
| Melius Research | Scott Davis | $458 | $285.59 | -50.1% | Oct 11, 2021 |
| Stifel Nicolaus | Nathan Jones | $342 | $285.59 | -62.8% | Oct 11, 2021 |
| Argus Research | John Eade | $345 | $311.6 | -62.4% | May 5, 2021 |
| Bank of America Securities | Andrew Obin | $385 | $309.85 | -58.1% | Apr 29, 2021 |
| Morgan Stanley | Joshua Pokrzywinski | $355 | $317.01 | -61.3% | Apr 12, 2021 |
Track every rating change on PH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationParker-Hannifin Corporation is a global enterprise specializing in the production and distribution of advanced motion and control technologies and systems. These solutions serve a broad spectrum of international markets, including mobile applications, industrial operations, and the aerospace sector. Its organizational structure is primarily divided into two key business units: Diversified Industrial and Aerospace Systems. Within the Diversified Industrial division, the product portfolio is extensive, covering sealing, protective shielding, thermal management systems, bonding agents, surface coatings, and technologies designed to reduce noise, vibration, and harshness. This segment also provides filtration units, diagnostic tools, and related solutions for purifying fuel, air, oil, water, and various other liquids and gases by eliminating contaminants.…
Historical context
All PH earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| UHAL U-Haul Holding Company | FY2027 Q2 · Calendar Q4 2026 | -15.4% | -3.2% | U-Haul Q2: Rental and storage growth, with execution risks |
| ITT ITT Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.7% | -2.5% | ITT Raises 2026 Outlook as Orders and Margins Strengthen |
| CMI Cummins Inc. | FY2026 Q3 · Calendar Q4 2026 | -6.0% | -4.9% | Data-center power demand supports Cummins, while outlook moderates |
| AXON Axon Enterprise, Inc. | FY2026 Q3 · Calendar Q4 2026 | -9.0% | -9.8% | Axon’s Q3 growth story meets investment, timing and margin questions |
| ROK Rockwell Automation, Inc. | FY2026 Q4 · Calendar Q4 2026 | +5.1% | -14.2% | Rockwell Automation Sets FY2027 Growth Outlook After Strong FY2026 |
Latest beats and misses
Who reports nextBeat on EPS
- FNFFY2026 Q3 · November 5, 20260.0% EPS+6.6% move
- MTDFY2026 Q3 · November 5, 2026+3.6% EPS+4.8% move
- IAGFY2026 Q3 · November 5, 2026+16.7% EPS+4.6% move
- GMABFY2026 Q3 · November 5, 2026+55.6% EPS-4.3% move
- STEFY2027 Q2 · November 4, 2026+9.7% EPS+2.5% move
- IRMFY2026 Q3 · November 5, 2026+4.6% EPS-11.1% move
Missed on EPS
- VMRKFY2026 Q3 · November 4, 2026-425.6% EPS+2.4% move
- NTRAFY2026 Q3 · November 5, 2026-49.3% EPS-15.2% move
- TIGOFY2026 Q3 · November 5, 2026-40.8% EPS+2.6% move
- UHALFY2027 Q2 · November 4, 2026-15.4% EPS-3.2% move
- LAMRFY2026 Q3 · November 5, 2026-3.6% EPS-0.8% move
- CMIFY2026 Q3 · November 5, 2026-6.0% EPS-4.9% move
Get the PH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-05T21:10:05.043188+00:00
- FN2 earnings calendar · 2026-11-06T01:23:16.275024+00:00
- Polygon adjusted daily market bars · 2026-11-06T13:20:51.055554+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-06T13:20:51.052872+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-06. For educational purposes only; not investment advice.